H. Kupferberg, Animal Models Used in the Screening of Antiepileptic Drugs, Epilepsia, vol.38, issue.suppl, pp.7-12, 2001.
DOI : 10.1111/j.1528-1167.2001.00002.x

W. Loscher, Animal models of intractable epilepsy, Progress in Neurobiology, vol.53, issue.2, pp.239-58, 1997.
DOI : 10.1016/S0301-0082(97)00035-X

D. Durand, Ictal Patterns in Experimental Models of Epilepsy, Journal of Clinical Neurophysiology, vol.10, issue.3, pp.281-97, 1993.
DOI : 10.1097/00004691-199307000-00004

S. Wallace, A Comparative Review of the Adverse Effects of Anticonvulsants in Children with Epilepsy, Drug Safety, vol.15, issue.6, pp.378-93, 1996.
DOI : 10.2165/00002018-199615060-00003

E. Perucca, L. Gram, and G. Avanzini, Antiepileptic Drugs as a Cause of Worsening Seizures, Epilepsia, vol.32, issue.1, pp.5-17, 1998.
DOI : 10.1016/0920-1211(88)90054-X

R. Guerrini, C. Dravet, and P. Genton, Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy, Epilepsia, vol.35, issue.5, pp.508-520, 1998.
DOI : 10.1016/0140-6736(92)91632-I

P. Quilichini, D. Diabira, and C. Chiron, in intact immature brain structures, European Journal of Neuroscience, vol.35, issue.5, pp.850-60, 2002.
DOI : 10.1046/j.1460-9568.2002.02143.x
URL : https://hal.archives-ouvertes.fr/inserm-00484869

I. Mody, J. Lambert, and U. Heinemann, Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices, J Neurophysiol, vol.57, pp.869-88, 1987.

R. Levy, R. Mattson, and B. Meldrum, Antiepileptic drugs, 1995.

W. Froscher, G. Kramer, and D. Schmidt, Serumkonzentration von Antiepileptika, Der Nervenarzt, vol.70, issue.2, pp.172-179, 1999.
DOI : 10.1007/s001150050419

O. Dulac, Epilepsies et convulsions de l'enfant. Encyclopédie Médico-Chirurgicale, pp.1-26, 1998.

M. Dichter and M. Brodie, New antiepileptic drugs, N Engl J Med, vol.334, pp.1583-90, 1996.

J. Pellock, T. Glauser, and E. Bebin, Pharmacokinetic Study of Levetiracetam in Children, Epilepsia, vol.20, issue.12, pp.1574-1583, 2001.
DOI : 10.1046/j.1528-1157.2001.41300.x

J. Claassen, L. Hirsch, and R. Emerson, Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review, Epilepsia, vol.50, issue.suppl 1, pp.146-53, 2002.
DOI : 10.1046/j.1528-1157.2002.28501.x

H. Yoshikawa, S. Yamazaki, and T. Abe, Midazolam as a first-line agent for status epilepticus in children, Brain and Development, vol.22, issue.4, pp.239-281, 2000.
DOI : 10.1016/S0387-7604(00)00116-9

J. Dreier, C. Zhang, and U. Heinemann, Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development, Acta Neurologica Scandinavica, vol.76, issue.2, pp.154-60, 1998.
DOI : 10.1111/j.1600-0404.1998.tb07286.x

C. Zhang, J. Dreier, and U. Heinemann, Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants, Epilepsy Research, vol.20, issue.2, pp.105-116, 1995.
DOI : 10.1016/0920-1211(94)00067-7

D. Engel, U. Endermann, and C. Frahm, Acute effects of ??-vinyl-GABA on low-magnesium evoked epileptiform activity in vitro, Epilepsy Research, vol.40, issue.2-3, pp.99-107, 2000.
DOI : 10.1016/S0920-1211(00)00112-1

U. Musshoff, R. Kohling, and A. Lucke, Vigabatrin reduces epileptiform activity in brain slices from pharmacoresistant epilepsy patients, European Journal of Pharmacology, vol.401, issue.2, pp.167-72, 2000.
DOI : 10.1016/S0014-2999(00)00420-9

S. Schuchmann, K. Buchheim, and H. Meierkord, A relative energy failure is associated with low-Mg 2+ but not with 4-aminopyridine induced seizure-like events in entorhinal cortex, J Neurophysiol, vol.81, pp.399-403, 1999.

D. Margineanu and H. Klitgaard, Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs, Pharmacological Research, vol.42, issue.4, pp.281-286, 2000.
DOI : 10.1006/phrs.2000.0689

J. Pellock and . Felbamate, Felbamate, Epilepsia, vol.26, issue.s5, pp.57-62, 1999.
DOI : 10.1021/tx960205e

M. Pfeiffer, A. Draguhn, and H. Meierkord, Effects of ??-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro, British Journal of Pharmacology, vol.35, issue.Suppl. 5, pp.569-77, 1996.
DOI : 10.1111/j.1476-5381.1996.tb15710.x

A. Sabau, C. Frahm, and M. Pfeiffer, Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro, European Journal of Pharmacology, vol.383, issue.3, pp.259-66, 1999.
DOI : 10.1016/S0014-2999(99)00628-7

U. Heinemann, C. Zhang, and C. Eder, Entorhinal cortex-hippocampal interactions in normal and epileptic temporal lobe, Hippocampus, vol.3, pp.89-97, 1993.

Y. Ishizawa, K. Furuya, and S. Yamagishi, Non-GABAergic effects of midazolam, diazepam and flumazenil on voltage-dependent ion currents in NG108-15 cells, NeuroReport, vol.8, issue.11, pp.2635-2643, 1997.
DOI : 10.1097/00001756-199707280-00042

H. Grunze and J. Walden, Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs, Magnes Res, vol.10, pp.119-145, 1997.

J. Von-wegerer, B. Hesslinger, and M. Berger, A calcium antagonistic effect of the new antiepileptic drug lamotrigine, European Neuropsychopharmacology, vol.7, issue.2, pp.77-81, 1997.
DOI : 10.1016/S0924-977X(96)00384-7

V. Libri, A. Constanti, and M. Zibetti, Effects of felbamate on muscarinic and metabotropic-glutamate agonist-mediated responses and magnesium-free or 4-aminopyridine-induced epileptiform activity in guinea pig olfactory cortex neurons in vitro, J Pharmacol Exp Ther, vol.277, pp.1759-69, 1996.

P. Kwan, G. Sills, and M. Brodie, The mechanisms of action of commonly used antiepileptic drugs, Pharmacology & Therapeutics, vol.90, issue.1, pp.21-34, 2001.
DOI : 10.1016/S0163-7258(01)00122-X

J. Rho and R. Sankar, The Pharmacologic Basis of Antiepileptic Drug Action, Epilepsia, vol.37, issue.11, pp.1471-83, 1999.
DOI : 10.1038/sj.bjp.0701941

A. Pugliese, M. Passani, and G. Pepeu, Felbamate decreases synaptic transmission in the CA1 region of rat hippocampal slices, J Pharmacol Exp Ther, vol.279, pp.1100-1108, 1996.

S. Birnstiel, E. Wulfert, and S. Beck, Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.356, issue.5, pp.611-619, 1997.
DOI : 10.1007/PL00005097

J. Gibbs, . Iii, S. Sombati, and R. Delorenzo, Cellular Actions of Topiramate: Blockade of Kainate-Evoked Inward Currents in Cultured Hippocampal Neurons, Epilepsia, vol.89, issue.s1, pp.10-16, 2000.
DOI : 10.1016/0306-4522(93)90004-Y

L. Overstreet and G. Westbrook, Paradoxical reduction of synaptic inhibition by vigabatrin, J Neurophysiol, vol.86, pp.596-603, 2001.

K. Backus, P. Pflimlin, and G. Trube, Action of diazepam on the voltage-dependent Na+ current. Comparison with the effects of phenytoin, carbamazepine, lidocaine and flumazenil, Brain Research, vol.548, issue.1-2, pp.41-50, 1991.
DOI : 10.1016/0006-8993(91)91104-9

E. Wyllie, Antiepileptic medications. The treatment of epilepsy: principles and practice, pp.821-68, 2001.